The expression of CXCR3 and CXCR4 has been shown to be downregulated upon activation and antigen exposure (44, 45), which supports the notion that DP CD8+ T cells with lower expression of CXCR3 and CXCR4 encounter their cognate tumor antigen. The gene discussed is CXCR3; the disease is neoplasm.